Neuropathic Pain Market: How the Market has witnessed Substantial Growth in recent years?

Neuropathic Pain Market Snapshot:

The global neuropathic pain market was valued at USD 2,052.9 million in 2018 and is expected to rise at a CAGR of 5.3% during the forecast period.

Neuropathic pain is caused when a disease damages the somatosensory nervous system.  People suffering from diabetes, vascular and blood problems, and kidney and liver disorders are highly prone to develop neuropathic pain. In addition, a high rate of ‘fall injuries’ can cause neurological diseases.  For instance, it was estimated that over 3 million geriatric people were treated in emergency departments, and 800,000 patients were hospitalized for fall injuries in the U.S. As per International Association of the pain,  around 7–8% of adults were registered to have neuropathic pain in 2015. Similarly, in the U. K., 26% diabetic people were found to have peripheral neuropathic pain worldwide.

Americas is housing huge population suffering from a variety of neurological issues such as stroke, Parkinson’s disease, brain cancer, epilepsy, brain injury, dementia, prion disease, Huntington’s disease, multiple sclerosis, and a host of neuromuscular conditions. For Instance, In U.S., around 235,000 cases of traumatic brain injuries are reported every year, which is in excess of 20 times the number of hospitalizations for spinal cord injury. Similarly, around 2.4% of the U.S. population suffered from peripheral neuropathy in 2015. As per National Institutes of Health estimation, around 165,813 people are currently living with brain and other nervous system disorders in the U.S. In the Americas, the prevalence of neuropathic disorders is increasing at an alarming rate. To curb the prevalence,  various organizations and pharmaceutical industries are focusing on the development of advanced treatment for neuropathic pain. As per the University of Maryland Medical Centers, in 2018, developed ultrasound treatment for neuropathic pain. In addition, FDA approved Lyrica for the management of neuropathic pain associated with diabetic peripheral neuropathy.
Spinal stenosis is one of the most common age-related back problems faced by the people in this region. Conforming  to the Cancer Research U.K., around 3–5 in 100 people are reported to suffer from cancer. People suffering from cancer have a high chance of developing spinal cord compression. In 2015, it was reported that around 2.9 million people were suffering from diabetes in the U.K. Therefore, the prevalence of spinal stenosis and diabetes mellitus in a person can increase their chances of developing neuropathic pain.

Obtain Brochure For Latest Technology Advancements @ 
https://straitsresearch.com/report/neuropathic-pain-market/request-sample

The Major Prominent Players Covered in this Report:
Pfizer Inc., Johnson & Johnson Services Inc., Bristol-Myers Squibb and Company, Eli Lily and Company, GlaxoSmithKline PLC, Sanofi S.A., Biogen Idec Inc., Baxter Healthcare Corporation, and Depomed Inc. & More.

By Type, Peripheral Neuropathy, Entrapment Neuropathy, Post Traumatic Neuropathy, Phantom Limb Pain, Post Herpetic Neuralgia (PHN),Trigeminal Neuralgia, Others
By Diagnosis and Treatment, Imaging, blood tests, physical examination, Medication, Multimodal therapy, Others Distribution Channel, Online Pharmacies, Retail Pharmacies, Drug Stores, Others
By End-User, Hospitals, Clinics, Research Organizations, Others

Growing Domestic Demand and Expanding Pharmaceutical Sector to Drive the Demand for Neuropathic Pain in the APAC Region
Asia-Pacific region is anticipated to hold the largest market share in the global Neuropathic Pain market during the forecast period 2019-2026. The growth in this region can be attributed to the presence of emerging economies like India, China, Japan, Vietnam, and Indonesia, which account for the largest share in this region. India is one of the largest producers of Neuropathic Pain and a major exporter of the product to various countries across the globe. India accounts for around 80% of the world’s exports of Neuropathic Pain. The favorable climatic conditions and growth of agricultural inputs and allied services like cold storage and warehousing in India are prompting higher production.

View this report with a detailed description and TOC @ 
https://straitsresearch.com/report/neuropathic-pain-market/toc

Key Questions Answered in The Report:
What will the Neuropathic Pain market growth rate?
What are the key factors driving the global Neuropathic Pain market?
Who are the key manufacturers in the Neuropathic Pain market space?
What are the market opportunities, market risk, and market overview of the Neuropathic Pain market?
What are sales, revenue, and price analysis of top manufacturers of the Neuropathic Pain market?
Who are the distributors, traders, and dealers of the Neuropathic Pain market?
What are the market opportunities and threats faced by the vendors in the global Steerable Medical Devices Industry?
What are sales, revenue, and price analysis by types and applications of the Neuropathic Pain Industry?
What are sales, revenue, and price analysis by regions of Neuropathic Pain industry?
What are the driving factors contributing to market growth during the short, medium, and long term?

Key Neuropathic Pain Market Trends:
- The report identifies, determines, and forecasts the Global Neuropathic Pain Market segments based on their type, sub-type, technology used, applications, end-users, and regions.
- Industry to Industry Holds Largest Share in the Neuropathic Pain Market
- It examines the micro-markets based on their growth trends, development patterns, future prospects, and contribution to the overall market.
- Demand from Regional / geographical is Expected to Drive the Growth
- Rising Adoption of Market Segments in this Growth
- North American, Europe is Expected to Witness Higher Growth Rate over the Forecast Period
- It studies the competitive developments such as partnerships and collaborations, mergers and acquisitions (M&A), research and development (R&D) activities, product developments, and expansions in the Global Neuropathic Pain Market.

Browse Full Report @ https://straitsresearch.com/report/neuropathic-pain-market/

Even if your business is a multinational venture or a single storefront, we believe innovation is the key to progress, in both what you build and how you promote your products and brands.

Buy Full Report with Detail Analysis with COVID-19 Impact – https://straitsresearch.com/buy-now/neuropathic-pain-market/global/

So let's put our minds together. We'll make your vision a reality and help you grow.

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com/

About Us:
Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enables us to determine greater insights by eliminating the research costs.

This release was published on openPR.